December 11, 2018
Shionogi and Ube Industries have concluded a strategic collaboration pact to research novel anti-respiratory syncytial virus (RSV) drug candidates, the two companies said on December 10. An infectious disease specialist, Shionogi already has candidate compounds targeting RSV. It hopes to...read more